Publication | Open Access
Rosuvastatin alleviates high-salt and cholesterol diet-induced cognitive impairment in rats via Nrf2–ARE pathway
16
Citations
41
References
2018
Year
We have investigated a novel mechanism of action for rosuvastatin (via the Nrf2-ARE pathway) and demonstrated that it has the potential to be used in the treatment of cognitive impairment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1